Skip to main content
Earnings Labs
Larimar Therapeutics, Inc. logo

Larimar Therapeutics, Inc. (LRMR)

NASDAQ·Healthcare·Biotechnology

$3.92

+2.34%

Mkt Cap $407.22M

Analyst Ratings

Buy

4

Hold

0

Sell

0

Price Target (9 analysts)

$8.00

Range $5.00$11.00

Implied Upside

+104.1%

Consensus $8.00 vs current $3.92